share_log

易瑞生物(300942.SZ):公司未来不排除通过并购重组提升竞争力

Huiray Biotechnology (300942.SZ): The company does not rule out enhancing its competitiveness through mergers and acquisitions in the future.

Gelonghui Finance ·  Dec 3, 2024 23:26

On December 4th, GELONGHUI reported that Eryi Biological (300942.SZ) stated during an investor relations event that from a global strategy perspective, the company does not rule out enhancing competitiveness through mergers and acquisitions, bringing value-added effects to the company and creating more value for shareholders.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment